health 66

To blame are the many undefined subtypes of mild cognitive impairment, a precursor to Alzheimer's disease. "Everyone thinks Alzheimer's is one disease , but it's not," said P. Murali Doraiswamy, M.D., professor of psychiatry and director of the neurocognitive disorders program at Duke Health. "There are many subgroups. If you enroll all different types of people in a trial, but your drug is targeting only one biological pathway, of course the people who don't have that abnormality are not going to respond to the drug, and the trial is going to fail." But if scientists grouped people with similar types of cognitive impairment, they could more precisely test the impact of investigational drugs, according to findings in a July 28 article in the journal  Scientific Reports , a publication of Nature Research. The research was jointly led by Dragan Gamberger, Ph.D., an artificial intelligence expert at the Rudjer Boskovic Institute in Croatia and ...

Marc Aurel Busche on the two-photon microscope, which permits to visualise nerve cells with excessive temporal and spatial decision within the intact mind. Credit score: Copyrighted picture: Kurt Bauer / Technical College of Munich The protein amyloid beta is believed to be the foremost reason behind Alzheimer's illness. Substances that cut back the manufacturing of amyloid beta, similar to BACE inhibitors, are due to this fact promising candidates for brand spanking new drug therapies. A crew on the Technical College of Munich (TUM) has just lately demonstrated that one such BACE inhibitor reduces the quantity of amyloid beta within the mind. By doing so, it may restore the conventional operate of nerve cells and considerably enhance reminiscence efficiency. Round 50 million folks worldwide endure from dementia. So far, no efficient drug is obtainable that is ready to halt or treatment the illness. Furthermore, the precise causes of the illness hav...

A new study from The Ohio State University has identified a potential new way of confirming the disease and predicting a patient's outlook. First, the team of researchers discovered new physical biomarkers that could help pinpoint a diagnosis -- changes to proteins found in the spinal fluid and blood of patients. In particular, as Alzheimer's severity increased, the proteins were longer, more rigid and more clustered, said lead researcher Mingjun Zhang, a professor of biomedical engineering at Ohio State. After finding these new clues to the disease, the research team entered information about the biomarkers and several other factors -- including scores from cognitive assessments of patients -- into an algorithm designed to rate the severity of illness. The researchers found that the equation could identify disease stages and progression. "With a tool like this you may predict how fast this disease will go, and currently we can't do that -- we just know ever...

Symptoms of Parkinson's disease are commonly managed using a selective dopamine receptor agonists. While these drugs are useful in early-stage Parkinson's, they tend to lose efficacy in later disease stages. As important, currently marketed drugs do not appear to modify disease progression. A research team including Binghamton University psychology  professor Chris Bishop and former graduate student David Lindenbach recently employed a preclinical model of Parkinson's disease to compare the effects of the dopamine agonist ropinirole to their new drug, known as D-512. Results demonstrated that D-512 was more efficacious than ropinirole in treating the symptoms of Parkinson's disease while also prolonging the time window in which the animals showed benefits. These findings followed on the heels of prior work by this collaborative group which demonstrated that D-512 may also protect again the progression of Parkinson's disease. "A major issue for Parkinson...

Kent State College researchers analyzed the brains of aged chimpanzees to point out pathology just like the human Alzheimer's illness mind. This picture exhibits tau-positive neuron (black) in proximity to amyloid deposits inside blood vessels (pink) in an aged chimpanzee mind. Credit score: Kent State College Dementia impacts one-third of all folks older than 65 years in america. The most typical reason behind dementia is Alzheimer's illness, a progressive , irreversible mind illness that leads to impaired cognitive functioning and different behavioral adjustments. People are thought of uniquely prone to Alzheimer's illness, doubtlessly resulting from genetic variations, adjustments in mind construction and performance throughout evolution, and an elevated lifespan. Nevertheless, a brand new research printed Aug. 1 in  Neurobiology of Growing old supplies essentially the most intensive proof of Alzheimer's illness mind pathology in a pri...

The research is the first large population-based study to prove that people with confusion caused by dementia or delirium, have inferior treatment outcomes, when compared with the rest of the population. Lead researcher, Professor Emma Reynish, Chair in Dementia Studies at the University of Stirling, said: "People with confusion -- or cognitive spectrum disorders -- make up over one-third of the population over 65 who are admitted as an emergency to hospital, and half of patients over the age of 85 years. "People who are admitted to hospital with confusion seem to do badly, and are at an increased risk of dying, increased risk of re-admission, and a hospital stay nearly two weeks longer than those without confusion. It is unclear whether this is as a result of the care that they are given or the disease process itself, or a combination of both. "People with confusion include: those with dementia; those with delirium -- a sudden change in someone's cognitive ...

Wine. Credit score: © stokkete / Fotolia Older adults who devour alcohol reasonably regularly usually tend to stay to the age of 85 with out dementia or different cognitive impairments than non-drinkers, in response to a College of California San Diego Faculty of Drugs-led research. The findings are revealed within the August problem of the  Journal of Alzheimer's Illness . Earlier research have discovered a correlation between average alcohol consumption and longevity. "This research is exclusive as a result of we thought-about women and men's cognitive well being at late age and located that alcohol consumption shouldn't be solely related to lowered mortality, however with better possibilities of remaining cognitively wholesome into older age," stated senior creator Linda McEvoy, PhD, an affiliate professor at UC San Diego Faculty of Drugs. Specifically, the researchers discovered that amongst women and men 85 and older, people who...

In a recent study, a research group from the Neurological Clinic of the University Hospital Ospedali Riuniti di Ancona and Marche Polytechnic University, Ancona, Italy, evaluated the reliability of the Framingham cardiovascular risk profile (FCRP) for the prediction of the evolution from mild cognitive impairment to AD. FCRP is a commonly adopted score used to calculate the risk of cardiovascular or cerebrovascular events along a 10-year period. Authors selected FCRP to evaluate if some common conditions, such as hypertension or diabetes , could be involved in increasing the risk of developing dementia. The results of this study are published in the Journal of Alzheimer's Disease. The study, coordinated by Mauro Silvestrini and Leandro Provinciali with Giovanna Viticchi as principal investigator, demonstrated that in subjects affected by mild cognitive impairment, the presence of high FCRP scores is associated to an increased risk of developing AD. These results could have a r...

PTSD is a brain disorder that can occur after experiencing a traumatic event. Individuals with PTSD frequently relive the traumatic event, often triggered by stimuli similar to those that accompanied the trauma. A number of epidemiological studies have shown that individuals suffering from PTSD are more prone to acquiring Alzheimer's disease later in their lives. Unravelling the molecular underpinnings of this correlation will help to identify targeted therapies. The research team in Göttingen identified such a molecular link by showing that Formin 2 is deregulated in PTSD and Alzheimer's disease patients. To investigate this link further, the researchers showed that Formin 2 mutant mice show PTSD phenotypes at an early age and develop age-related memory decline. On the molecular level, Formin 2 is active in the brain, where it regulates the dynamics of the cytoskeleton, the structure that helps cells to maintain their shape and internal organization. It is required for ...

Results of the research were published online in the  Journal of Alzheimer's Disease . Senior author Dr. Tetyana Zayats is a researcher at the KGJebsen Centre for Neuropsychiatric Disorders at the University of Bergen. The study analyzed genetic markers and IQ collected from 5,165 children in the Avon Longitudinal Study of Parents and Children. The genetic findings were followed up in the genetic data from two adult datasets (1) 17,008 cases with AD and 37,154 controls, and (2) 112,151 individuals assessed for general cognitive functioning. The function of the genetic markers was analysed using reporter assays in cells. Brain cells communicate via synapses containing hundreds of specialized proteins. Mutations in some of these proteins lead to dysfunctional synapses and brain diseases such as epilepsy, intellectual disability, autism or AD. Dr. Zayats and co-workers at the University of Bergen examined a subgroup of these proteins that have been implicated in synaptic plastic...